GPs, pharmacists and geriatricians from across the country gathered at the Royal Pharmaceutical Society in London on Thursday 23 November to celebrate five years since the launch of the Polypharmacy Action Learning Sets.
The Action Learning Sets are an evidenced-based education approach to upskill primary care professionals in addressing problematic or unnecessary polypharmacy in their patients.
Speakers included Professor Tony Avery, NHS England’s National Clinical Lead for Prescribing; Dr Lucy Pollock, Consultant Geriatrician at Somerset NHS Foundation Trust, and author of ‘The Book About Getting Older’; David Webb, NHS England’s Chief Pharmaceutical Officer; Adam Todd, Professor of Pharmaceutical Public Health at Newcastle University; and Clare Howard, Clinical Lead for the Health Innovation Network’s national Polypharmacy programme.
The Action Learning Sets form an important part of our national Polypharmacy Programme, which is supporting healthcare professionals to identify patients at potential risk from harm and facilitate better conversations about medicines.
Action Learning Sets are a structured method enabling small groups to explore complicated issues by meeting regularly and working collectively. We have used the approach to support GPs, pharmacists and other healthcare professionals who undertake prescribing or medication reviews to understand the complex issues around stopping inappropriate medicines safely.
As of November 2023, 638 delegates across England have participated in the Polypharmacy Action Learning Sets. Our ambition is to increase this number to 1,000 by March 2024.
At the celebration event we launched our ‘state of the nation’ report, showcasing the learning from our Action Learning Sets and providing recommendations for change. The insights detailed in the report include:
- Confidence amongst GPs and pharmacists to stop medicines safely is a significant issue.
- Shared decision making with the patient is the key to solving problematic polypharmacy.
- Primary care has the data and the tools but both clinicians and patients need more support to use these effectively.
- Geriatricians see the impact of overprescribing and they are essential to help primary care tackle the issue.
- Primary care networks (PCNs) are hugely variable in the make-up and some roles under the Additional Roles Reimbursement Scheme (ARRS) need much more support.
- We need to engage our secondary care colleagues in this work going forward.
- Funding needs to be guaranteed and for a minimum of two years (ideally five) to continue successful delivery of a robust and well-resourced training offer to GPs and pharmacists.
- We need to establish a deprescribing network in England.
Download the full report here.
The event also featured posters created by Action Learning Set delegates on a wide range of quality improvement (QI) projects they have undertaken to address problematic polypharmacy in their workplace to drive and accelerate changes in practice.
Take a look at the Polypharmacy QI posters here.
Watch our short film to find out more about our Polypharmacy Action Learning Sets.
Register your interest to join a future Polypharmacy Action Learning Set here.
The NHS Innovation Accelerator (NIA) has revealed its 2025 cohort of Fellows. As the NIA celebrates a decade of helping to drive innovation in the NHS, this year’s cohort aligns with the Government’s three priorities: supporting the transition from analogue to digital, sickness to prevention and hospital to home. The 28 new Fellows will benefit [...]
A new guide aimed at helping primary care organisations and integrated care boards understand and address problematic polypharmacy has been launched by the Health Innovation Network as part of its national Polypharmacy Programme. Developed in response to a clear need identified by primary care and prescribing colleagues, this essential resource provides practical, evidence-based strategies to [...]
Across England, innovation is improving cancer services and patient outcomes. Last week the government launched an open call for evidence to inform the National Cancer Plan. Innovation has a critical role to play in supporting the delivery of any National Cancer Plan, and delivering on the government’s three shifts. In order to realise the significant [...]
